Cahya Mata Sarawak Berhad (KLSE:CMSB)

Market Cap	1.31B
Revenue (ttm)	1.17B
Net Income (ttm)	115.28M
Shares Out	1.07B
EPS (ttm)	0.11
PE Ratio	11.41
Forward PE	8.38
Dividend	0.03 (2.46%)
Ex-Dividend Date	Jun 4, 2025

Volume	4,191,500
Average Volume	8,000,375
Open	1.210
Previous Close	1.200
Day's Range	1.200 - 1.240
52-Week Range	0.785 - 1.460
Beta	1.26
RSI	49.37
Earnings Date	Aug 28, 2025

About Theseus Pharmaceuticals

Cahya Mata Sarawak Berhad, an investment holding company, engages in the manufacture and trading of cement and construction materials in Malaysia and internationally. The company operates through seven segments: Cement, Road Maintenance, Property Development, Phosphate, Oiltools, Strategic Investments, and Support Services. The Cement segment produces cement, clinker, and concrete products. The Road Maintenance segment engages in road construction and maintenance works. The Property Development segment is involved in property holding, developme...

• Industry: Cement, Hydraulic
• Founded: 1974
• Employees: 2,000
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: CMSB

Financial Performance

In 2024, Cahya Mata Sarawak Berhad's revenue was 1.20 billion, a decrease of -0.39% compared to the previous year's 1.20 billion. Earnings were 128.19 million, an increase of 12.01%.